Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Amin, AsimPlimack, Elizabeth RErnstoff, Marc SLewis, Lionel DBauer, Todd MMcDermott, David FCarducci, MichaelKollmannsberger, ChristianRini, Brian IHeng, Daniel Y CKnox, JenniferVoss, Martin HSpratlin, JenniferBerghorn, ElmerYang, LingfengHammers, Hans J2019-03-172019-03-172019-03-14Journal for ImmunoTherapy of Cancer. 2019 Mar 14;7(1):73http://hdl.handle.net/1880/110080https://doi.org/10.11575/PRISM/44802.Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 studyunknown2019-03-17enThe Author(s).https://doi.org/10.1186/s40425-019-0559-3